cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Annovis Bio
5 own
4 watching
Current Price
$18.92
$-1.16
(-5.78%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
97.56M
52-Week High
52-Week High
23.9099
52-Week Low
52-Week Low
8.385
Average Volume
Average Volume
0.11M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization97.56M
icon52-Week High23.9099
icon52-Week Low8.385
iconAverage Volume0.11M
iconDividend Yield--
iconP/E Ratio--
What does the Annovis Bio do?
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company s lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Read More
How much money does Annovis Bio make?
News & Events about Annovis Bio.
PR Newswire
1month ago
Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team PR Newswire BERWYN, Penn., Jan. 6, 2023 BERWYN, Penn., Jan. 6, 2023 /PRNewswire/ --Annovis Bio, Inc.(NYSE:ANVS) ('Annovis' or the...
PR Newswire
7 months ago
Thinking about buying stock in Inspira Technologies, Annovis Bio, Tenneco, Benitec Biopharma, or Surface Oncology? Thinking about buying stock in Inspira Technologies, Annovis Bio, Tenneco, Benitec Biopharma, or Surface Oncology? PR Newswire NEW YORK, July 7, 2022 NEW YORK, July 7, 2022...
Zolmax
8 months ago
Annovis Bio (NYSE:ANVS Get Rating) and Atreca (NASDAQ:BCEL Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, ...
Frequently Asked Questions
Frequently Asked Questions
What is Annovis Bio share price today?
plus_minus_icon
Can Indians buy Annovis Bio shares?
plus_minus_icon
How can I buy Annovis Bio shares from India?
plus_minus_icon
Can Fractional shares of Annovis Bio be purchased?
plus_minus_icon
What are the documents required to start investing in Annovis Bio stocks?
plus_minus_icon
What is today’s traded volume of Annovis Bio?
plus_minus_icon
What is today’s market capitalisation of Annovis Bio?
plus_minus_icon
What is the 52-Week High and Low Range of Annovis Bio?
plus_minus_icon
What percentage is Annovis Bio down from its 52-Week High?
plus_minus_icon
What percentage is Annovis Bio up from its 52-Week Low?
plus_minus_icon
Current Price
$18.92
$-1.16
(-5.78%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00